* BioTime - Deconsolidation of Oncocyte's financial's from co's consolidated financial statements; co to report pro forma non-cash gain of about $56 million Sign up here. * BioTime Inc- amount of gain ...
Asterias Biotherapeutics, Inc. and BioTime, Inc. (NYSE MKT: BTX) jointly announced today the closing of the transactions under the Asset Contribution Agreement (the "Agreement") with Geron Corporation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results